NCT02909777View on ClinicalTrials.gov

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
LymphomaNeuroblastomaBrain TumorSolid Tumor
Interventions
DRUG

CUDC-907

Trial Locations (4)

19104

Children's Hospital of Philadelphia, Philadelphia

77030

Texas Children's, Baylor College of Medicine, Houston

94158

University of California, San Francisco, Benioff Children's Hospital, San Francisco

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Curis, Inc.

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER